141 related articles for article (PubMed ID: 12189014)
1. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
Mateos-Trigos G; Evans RJ; Heath MF
Platelets; 2002; 13(5-6):285-92. PubMed ID: 12189014
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
3. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
Storey RF; Newby LJ; Heptinstall S
Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation.
Eckly A; Gendrault JL; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2001 Apr; 85(4):694-701. PubMed ID: 11341507
[TBL] [Abstract][Full Text] [Related]
5. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
Oliver JA; Albrecht RM
Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.
Ingall AH; Dixon J; Bailey A; Coombs ME; Cox D; McInally JI; Hunt SF; Kindon ND; Teobald BJ; Willis PA; Humphries RG; Leff P; Clegg JA; Smith JA; Tomlinson W
J Med Chem; 1999 Jan; 42(2):213-20. PubMed ID: 9925726
[TBL] [Abstract][Full Text] [Related]
8. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
[TBL] [Abstract][Full Text] [Related]
10. ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors.
Jarvis GE; Humphries RG; Robertson MJ; Leff P
Br J Pharmacol; 2000 Jan; 129(2):275-82. PubMed ID: 10694233
[TBL] [Abstract][Full Text] [Related]
11. P2y(12), a new platelet ADP receptor, target of clopidogrel.
Savi P; Labouret C; Delesque N; Guette F; Lupker J; Herbert JM
Biochem Biophys Res Commun; 2001 May; 283(2):379-83. PubMed ID: 11327712
[TBL] [Abstract][Full Text] [Related]
12. Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function.
Natarajan P; May JA; Sanderson HM; Zabe M; Spangenberg P; Heptinstall S
Platelets; 2000 Dec; 11(8):467-76. PubMed ID: 11177446
[TBL] [Abstract][Full Text] [Related]
13. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
Puri RN; Colman RW
Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919
[TBL] [Abstract][Full Text] [Related]
14. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
Jin J; Tomlinson W; Kirk IP; Kim YB; Humphries RG; Kunapuli SP
Br J Pharmacol; 2001 Jun; 133(4):521-8. PubMed ID: 11399669
[TBL] [Abstract][Full Text] [Related]
15. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the human P2Y11 receptor.
Communi D; Robaye B; Boeynaems JM
Br J Pharmacol; 1999 Nov; 128(6):1199-206. PubMed ID: 10578132
[TBL] [Abstract][Full Text] [Related]
17. Platelet adhesion to collagen is inhibited by adenosine diphosphate but unaffected by cell shape.
Meyer FA; Weisman Z; Frojmovic MM
Thromb Haemost; 1981 Aug; 46(2):515-20. PubMed ID: 7302891
[TBL] [Abstract][Full Text] [Related]
18. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
Peerschke EI; Zucker MB
Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
Steen VM; Holmsen H
Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
[TBL] [Abstract][Full Text] [Related]
20. Identification of two distinct adenosine diphosphate receptors in human platelets.
Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
